Colgate-Palmolive (CL)

• Market cap: $66B
• 1 day: -0.64%
• 5 days: -2.46%
• 1 month: -3.05%
• 3 months: -7.37%
• 6 months: -8.72%
• Year to date: -9.78%
• 1 year: -20.83%
• 5 years: 7.73%
• 10 years: 30.31%
• Sector: Consumer Staples
• Industry: Household & Personal Products

About: Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for north of 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries. International sales account for about 70% of its total business, including approximately 45% from emerging regions. It also owns specialty pet food maker Hill's (around one-fifth of sales), which sells a majority of its products through veterinarians and specialty pet retailers.

Employees: 34,000

Fund manager confidence

Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)

15% more call options, than puts

Call options by funds: $309M | Put options by funds: $269M

3% more first-time investments, than exits

New positions opened: 124 | Existing positions closed: 120

0.68% more ownership

Funds ownership: 82.61% [Q1] → 83.29% (+0.68%) [Q2]

2% less capital invested

Capital invested by funds: $62.8B [Q1] → $61.2B (-$1.57B) [Q2]

2% less funds holding

Funds holding: 1,913 [Q1] → 1,880 (-33) [Q2]

17% less repeat investments, than reductions

Existing positions increased: 626 | Existing positions reduced: 751

17% less funds holding in top 10

Funds holding in top 10: 12 [Q1] → 10 (-2) [Q2]

Research analyst outlook

6 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $83
• Avg. target: $95
• High target: $106

6 analyst ratings

• positive: 4 67%
• neutral: 1 17%
• negative: 1 17%

Citigroup Filippo Falorni	$105	Buy Maintained	4 Aug 2025
JP Morgan Andrea Teixeira	$95	Overweight Maintained	4 Aug 2025
Morgan Stanley Dara Mohsenian	$96	Overweight Maintained	4 Aug 2025
Wells Fargo Chris Carey	$83	Underweight Maintained	4 Aug 2025
UBS Peter Grom	$106	Buy Maintained	17 Jul 2025